This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient receives a neuromuscular blocking agent before a procedure. The patient's eyes close. The ... (Read 37 times)

hbsimmons88

  • Hero Member
  • *****
  • Posts: 526
on: Jul 23, 2018
A patient receives a neuromuscular blocking agent before a procedure. The patient's eyes close. The nurse knows this is a sign that the patient:
 
  a. has fallen asleep.
  b. has received a toxic dose of the medica-tion.
  c. is beginning to feel the drug's effects.
  d. may need mechanical ventilation.

Question 2

Which drugs are used to treat COPD? (Select all that apply.)
 
  a. Anticholinergic medications
  b. Glucocorticoids
  c. Leukotriene modifiers
  d. Long-acting beta2 agonists
  e. Monoclonal antibodies


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cegalasso

  • Sr. Member
  • ****
  • Posts: 295
Reply #1 on: Jul 23, 2018
Answer to Question 1

C
Neuromuscular blocking agents relax skeletal muscle to produce flaccid paralysis; the first mus-cles to be affected are the levator muscle of the eyelids and the muscles of mastication. These agents do not affect the CNS. Because the drug has just taken effect, a toxic dose is not yet a concern. Mechanical ventilation is necessary when the drug affects the intercostal muscles and the diaphragm, interfering with respiration.

Answer to Question 2

A, B, D
Anticholinergic drugs, glucocorticoids, and LABAs are used to treat COPD. Leukotriene mod-ifiers and monoclonal antibodies are used only to treat asthma.


hbsimmons88

  • Member
  • Posts: 526
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review

Dominic

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Great answer, keep it coming :)

« previous next »
 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

A close-up of the migrating snails. A close-up of the migrating snails.
Immunization with a vaccine. A healthcare professional is injecting a vaccine into the patient’s arm Immunization with a vaccine. A healthcare professional is injecting a vaccine into the patient’s arm
THE DIMENSIONS OF PATIENT-CENTERED CARE THE DIMENSIONS OF PATIENT-CENTERED CARE
Medical assistant shaking hands with the interviewer at the close of the interview. Medical assistant shaking hands with the interviewer at the close of the interview.
Tumor marker analysis of a patient with no evidence of disease monitored for tumor recurrence. The ... Tumor marker analysis of a patient with no evidence of disease monitored for tumor recurrence. The ...
Close-up of a newly created enzyme degrading PET plastic Close-up of a newly created enzyme degrading PET plastic
Video: Helper T cell receptors, activation, proliferation, differentiation & action

For a complete list of videos, visit our video library